|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Chen C, Huang X, Peng M, Liu W, Yu F and
Wang X: Multiple primary lung cancer: A rising challenge. J Thorac
Dis. 11 (Suppl 4):S523–S536. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Gazdar AF and Minna JD: Multifocal lung
cancers-clonality vs field cancerization and does it matter? J Natl
Cancer Inst. 101:541–543. 2009.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Samadzadeh Tabrizi N, Gallant B, Harris E,
Arnold BN and Fabian T: Contemporary incidence of synchronous
multiple primary lung cancers and survival in the era of lung
cancer screening. Innovations (Phila). 19:23–29. 2024.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Zhang DY, Liu J, Zhang Y, Ye JY, Hu S,
Zhang WX, Yu DL and Wei YP: One-stage resection of four genotypes
of bilateral multiple primary lung adenocarcinoma: A case report.
World J Clin Cases. 10:10301–10309. 2022.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Cheng H, Li WH, Li XJ, Zhong HC, Wang XJ,
Lin YJ, Liu XG, Wu XW and Cao QD: Small nodules (≤6 mm in diameter)
of multiple primary lung cancers: Prevalence and management. J
Cardiothorac Surg. 17(278)2022.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Zhang Z, Gao S, Mao Y, Mu J, Xue Q, Feng X
and He J: Surgical outcomes of synchronous multiple primary
non-small cell lung cancers. Sci Rep. 6(23252)2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Kawai H, Iguchi K, Takayashiki N, Okauchi
S and Satoh H: Metachronous isolated contralateral lung metastasis
from pulmonary adenosquamous carcinoma with EGFR mutation. Acta
Medica (Hradec Kralove). 63:141–144. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Nie Y, Wang X, Yang F, Zhou Z, Wang J and
Chen K: Surgical prognosis of synchronous multiple primary lung
cancer: Systematic review and meta-analysis. Clin Lung Cancer.
22:341–350.e3. 2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zhang H, Liu Q, Chen L, Song L, Mao F,
Zhou W, Li J, Song Z, Miao W and Shentu Y: Identification of the
prognostic factors for synchronous multiple primary lung cancer
treated with staged bilateral surgery. Clin Respir J.
18(e70017)2024.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Liu M, He W, Yang J and Jiang G: Surgical
treatment of synchronous multiple primary lung cancers: A
retrospective analysis of 122 patients. J Thorac Dis. 8:1197–1204.
2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Wang L, Yu J, Luo Y, Nie J, Ge X, Li Y,
Hua B and Liu R: The intersection of artificial intelligence and
lung nodule research: Current applications and future prospects.
Int J Surg: January 13, 2026 (Epub ahead of print).
|
|
13
|
Astaraki M, Zakko Y, Toma Dasu I, Smedby Ö
and Wang C: Benign-malignant pulmonary nodule classification in
low-dose CT with convolutional features. Phys Med. 83:146–153.
2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Schneider F and Dacic S: Histopathologic
and molecular approach to staging of multiple lung nodules. Transl
Lung Cancer Res. 6:540–549. 2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Zheng R, Shen Q, Mardekian S, Solomides C,
Wang ZX and Evans NR III: Molecular profiling of key driver genes
improves staging accuracy in multifocal non-small cell lung cancer.
J Thorac Cardiovasc Surg. 160:e71–e79. 2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Motono N, Matsui T, Machida Y, Usuda K and
Uramoto H: Prognostic significance of histologic subtype in pStage
I lung adenocarcinoma. Med Oncol. 34(100)2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Travis WD, Asamura H, Bankier AA, Beasley
MB, Detterbeck F, Flieder DB, Goo JM, MacMahon H, Naidich D,
Nicholson AG, et al: The IASLC lung cancer staging project:
Proposals for coding T categories for subsolid nodules and
assessment of tumor size in part-solid tumors in the forthcoming
eighth edition of the TNM classification of lung cancer. J Thorac
Oncol. 11:1204–1223. 2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Shih AR, Uruga H, Bozkurtlar E, Chung JH,
Hariri LP, Minami Y, Wang H, Yoshizawa A, Muzikansky A, Moreira AL
and Mino-Kenudson M: Problems in the reproducibility of
classification of small lung adenocarcinoma: An international
interobserver study. Histopathology. 75:649–659. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Cohen JG, Reymond E, Jankowski A,
Brambilla E, Arbib F, Lantuejoul S and Ferretti GR: Lung
adenocarcinomas: Correlation of computed tomography and pathology
findings. Diagn Interv Imaging. 97:955–963. 2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Feng SH and Yang ST: The new 8th TNM
staging system of lung cancer and its potential imaging
interpretation pitfalls and limitations with CT image
demonstrations. Diagn Interv Radiol. 25:270–279. 2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Liang Z, Zeng G, Wan W, Deng B, Chen C, Li
F, Lin G, Lin Y, Lin H, Mo G and Miao H: The unique genetic
mutation characteristics based on large panel next-generation
sequencing (NGS) detection in multiple primary lung cancers (MPLC)
patients. Discov Med. 35:131–143. 2023.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Kozower BD, Larner JM, Detterbeck FC and
Jones DR: Special treatment issues in non-small cell lung cancer:
Diagnosis and management of lung cancer, 3rd ed: American college
of chest physicians evidence-based clinical practice guidelines.
Chest. 143 (5 Suppl):e369S–e399S. 2013.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Travis WD, Brambilla E, Noguchi M,
Nicholson AG, Geisinger KR, Yatabe Y, Beer DG, Powell CA, Riely GJ,
Van Schil PE, et al: International association for the study of
lung cancer/american thoracic society/european respiratory society
international multidisciplinary classification of lung
adenocarcinoma. J Thorac Oncol. 6:244–285. 2011.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Takamochi K, Oh S, Matsuoka J and Suzuki
K: Clonality status of multifocal lung adenocarcinomas based on the
mutation patterns of EGFR and K-ras. Lung Cancer. 75:313–320.
2012.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Homer RJ: Pathologists' staging of
multiple foci of lung cancer: Poor concordance in absence of
dramatic histologic or molecular differences. Am J Clin Pathol.
143:701–706. 2015.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Stefanidis K, Konstantellou E, Yusuf G,
Moser J, Tan C and Vlahos I: The evolving landscape of lung cancer
surgical resection: An update for radiologists with focus on key
chest ct findings. AJR Am J Roentgenol. 218:52–65. 2022.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Jiang L, Zheng X, Wu S, Zhang J, Ru G and
Li Y: A rare case of synchronous multiple primary lung cancer:
Squamous cell cancer and small cell lung cancer. Onco Targets Ther.
12:8801–8806. 2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Román A, Perez-Rozos A, Otero A, Jodar C,
García-Ríos I, Lupiañez-Perez Y, Antonio Medina J and Gomez-Millan
J: Efficacy and safety of a simplified SBRT regimen for central and
peripheral lung tumours. Clin Transl Oncol. 22:144–150.
2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Patrini D, Panagiotopoulos N, Bedetti B,
Mitsos S, Crisci R, Solli P, Bertolaccini L and Scarci M: Surgical
approach in oligometastatic non-small cell lung cancer. Ann Transl
Med. 6(93)2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Kawaguchi T, Takeda M, Yoshikawa D, Taiji
R, Yamada A, Miyata R, Hamaji M, Hosono M and Sawabata N: Pulmonary
metastases from pancreatic cancer have different
clinico-radiological features compared with those from colorectal
cancer. Jpn J Clin Oncol. 54:1314–1320. 2024.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Yu Y, Zhu J, Zhou Y, Sang S, Zhu Y and
Zhang X: Imaging characteristics and prognostic value of isolated
pulmonary metastasis from colorectal cancer demonstrated
with18F-FDG PET/CT. Biomed Res Int.
2022(2230079)2022.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Liu Y, Tang Y, Xue Z, Jin X, Ma G, Zhao P
and Chu X: SUVmax ratio on PET/CT may differentiate between lung
metastases and synchronous multiple primary lung cancer. Acad
Radiol. 27:618–623. 2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Dai L, Yang HL, Yan WP, Liang Z, Xiong HC,
Kang XZ, Yang YB, Fu H, Fan MY and Chen KN: The equivalent efficacy
of multiple operations for multiple primary lung cancer and a
single operation for single primary lung cancer. J Thorac Dis.
8:855–861. 2016.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Tie H, Luo J, Shi R, Li Z, Chen D and Wu
Q: Characteristics and prognosis of synchronous multiple primary
lung cancer after surgical treatment: A systematic review and
meta-analysis of current evidence. Cancer Med. 10:507–520.
2021.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Liu XD, Qu Y and Lu SS: Synchronous double
primary lung cancer: A report of three cases. Chin J Cancer Res.
26:E17–E21. 2014.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Yang H, Sun Y, Yao F, Yu K, Gu H, Han B
and Zhao H: Surgical therapy for bilateral multiple primary lung
cancer. Ann Thorac Surg. 101:1145–1152. 2016.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Ichinokawa H, Sowa T, Yaguchi T, Oizumi H,
Takamochi K and Suzuki K: Six radical surgeries for metachronous
multiple primary lung cancer: A case report. Int J Surg Case Rep.
127(110860)2025.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Kocaturk CI, Gunluoglu MZ, Cansever L,
Demir A, Cinar U, Dincer SI and Bedirhan MA: Survival and
prognostic factors in surgically resected synchronous multiple
primary lung cancers. Eur J Cardiothorac Surg. 39:160–166.
2011.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Zhao L, Liu C, Xie G, Wu F and Hu C:
Multiple primary lung cancers: A new challenge in the era of
precision medicine. Cancer Manag Res. 12:10361–10374.
2020.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Detterbeck FC, Jones DR, Kernstine KH and
Naunheim KS: American College of Physicians. Lung cancer. Special
treatment issues. Chest. 123 (1 Suppl):244S–258S. 2003.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Donfrancesco E, Yvorel V, Casteillo F,
Stachowicz ML, Patoir A, Tiffet O, Péoc'h M and Forest F:
Histopathological and molecular study for synchronous lung
adenocarcinoma staging. Virchows Arch. 476:835–842. 2020.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Takahashi K, Kohno T, Matsumoto S,
Nakanishi Y, Arai Y, Yamamoto S, Fujiwara T, Tanaka N and Yokota J:
Clonal and parallel evolution of primary lung cancers and their
metastases revealed by molecular dissection of cancer cells. Clin
Cancer Res. 13:111–120. 2007.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Lu X, Xu Q, Wang J, Bi J, Wang Z and Li Y:
Allele frequency of somatic mutations in individuals reveals
signatures of cancer-related genes. Acta Biochim Biophys Sin
(Shanghai). 47:657–660. 2015.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Yatabe Y, Matsuo K and Mitsudomi T:
Heterogeneous distribution of EGFR mutations is extremely rare in
lung adenocarcinoma. J Clin Oncol. 29:2972–2977. 2011.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Mansuet-Lupo A, Barritault M, Alifano M,
Janet-Vendroux A, Zarmaev M, Biton J, Velut Y, Le Hay C, Cremer I,
Régnard JF, et al: Proposal for a combined histomolecular algorithm
to distinguish multiple primary adenocarcinomas from intrapulmonary
metastasis in patients with multiple lung tumors. J Thorac Oncol.
14:844–856. 2019.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Yang R, Li P, Wang D, Wang L, Yin J, Yu B,
Li M, Wang S and Wang Y: Genetic and immune characteristics of
multiple primary lung cancers and lung metastases. Thorac Cancer.
12:2544–2550. 2021.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Han Y, Geng Y, Sui Q, Liu Y, Xie S, Gao M,
Liu Q, Liu G and Wang S: When multiple primary lung cancers express
the same rare mutation: A case report. Front Oncol.
14(1475193)2024.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Thomas V, Rashed A, Faul C, Nicholson S,
Young V, Hanson J, Hennessy BT, Toomey S and Furney SJ: Genome
sequencing of multiple primary lung cancers harbouring mixed
histology and spontaneously regressing small-cell lung cancer. J
Pers Med. 14(257)2024.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Saab J, Zia H, Mathew S, Kluk M, Narula N
and Fernandes H: Utility of genomic analysis in differentiating
synchronous and metachronous lung adenocarcinomas from primary
adenocarcinomas with intrapulmonary metastasis. Transl Oncol.
10:442–449. 2017.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Shimada Y, Saji H, Otani K, Maehara S,
Maeda J, Yoshida K, Kato Y, Hagiwara M, Kakihana M, Kajiwara N, et
al: Survival of a surgical series of lung cancer patients with
synchronous multiple ground-glass opacities, and the management of
their residual lesions. Lung Cancer. 88:174–180. 2015.PubMed/NCBI View Article : Google Scholar
|
|
51
|
MacMahon H, Naidich DP, Goo JM, Lee KS,
Leung ANC, Mayo JR, Mehta AC, Ohno Y, Powell CA, Prokop M, et al:
Guidelines for management of incidental pulmonary nodules detected
on CT images: From the fleischner society 2017. Radiology.
284:228–243. 2017.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Jiang G, Chen C, Zhu Y, Xie D, Dai J, Jin
K, Shen Y, Wang H, Li H, Zhang L, et al: Shanghai pulmonary
hospital experts consensus on the management of ground-glass
nodules suspected as lung adenocarcinoma (version 1). Zhongguo Fei
Ai Za Zhi. 21:147–159. 2018.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
53
|
Genshaft SJ, Suh RD, Abtin F, Baerlocher
MO, Dariushnia SR, Devane AM, Himes E, Lisberg A, Padia S, Patel S
and Yanagawa J: Society of interventional radiology quality
improvement standards on percutaneous ablation of non-small cell
lung cancer and metastatic disease to the lungs. J Vasc Interv
Radiol. 32:1242.e1–1242.e10. 2021.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Ambrogi MC, Fanucchi O, Dini P, Melfi F,
Davini F, Lucchi M, Massimetti G and Mussi A: Wedge resection and
radiofrequency ablation for stage I nonsmall cell lung cancer. Eur
Respir J. 45:1089–1097. 2015.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Yang X, Ye X, Lin Z, Jin Y, Zhang K, Dong
Y, Yu G, Ren H, Fan W, Chen J, et al: Computed tomography-guided
percutaneous microwave ablation for treatment of peripheral
ground-glass opacity-lung adenocarcinoma: A pilot study. J Cancer
Res Ther. 14:764–771. 2018.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Kodama H, Yamakado K, Hasegawa T, Takao M,
Taguchi O, Fukai I and Sakuma H: Radiofrequency ablation for
ground-glass opacity-dominant lung adenocarcinoma. J Vasc Interv
Radiol. 25:333–339. 2014.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Iguchi T, Hiraki T, Gobara H, Fujiwara H,
Matsui Y, Soh J, Toyooka S, Kiura K and Kanazawa S: Percutaneous
radiofrequency ablation of lung cancer presenting as ground-glass
opacity. Cardiovasc Intervent Radiol. 38:409–415. 2015.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Huang G, Yang X, Li W, Wang J, Han X, Wei
Z, Meng M, Ni Y, Zou Z, Wen Q, et al: A feasibility and safety
study of computed tomography-guided percutaneous microwave
ablation: A novel therapy for multiple synchronous ground-glass
opacities of the lung. Int J Hyperthermia. 37:414–422.
2020.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Liu B and Ye X: Computed tomography-guided
percutaneous microwave ablation: A novel perspective to treat
multiple pulmonary ground-glass opacities. Thorac Cancer.
11:2385–2388. 2020.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Chang JC, Alex D, Bott M, Tan KS, Seshan
V, Golden A, Sauter JL, Buonocore DJ, Vanderbilt CM, Gupta S, et
al: Comprehensive next-generation sequencing unambiguously
distinguishes separate primary lung carcinomas from intrapulmonary
metastases: comparison with standard histopathologic approach. Clin
Cancer Res. 25:7113–7125. 2019.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Heeke AL, Elliott A, O'Keefe K, Livasy C,
Symanowski JT, Steiner MR, Kang IM, Hoon DSB, Walker P, Sledge GW,
et al: Human epidermal growth factor receptor 2 alterations and
prognostic implications in all subtypes of breast cancers. JCO
Precis Oncol. 9(e2300719)2025.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Chang JY, Lin SH, Dong W, Liao Z, Gandhi
SJ, Gay CM, Zhang J, Chun SG, Elamin YY, Fossella FV, et al:
Stereotactic ablative radiotherapy with or without immunotherapy
for early-stage or isolated lung parenchymal recurrent
node-negative non-small-cell lung cancer: An open-label,
randomised, phase 2 trial. Lancet. 402:871–881. 2023.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Cheng B, Li C, Zhao Y, Li J, Xiong S,
Liang H, Liu Z, Zeng W, Liang W and He J: The impact of
postoperative EGFR-TKIs treatment on residual GGO lesions after
resection for lung cancer. Signal Transduct Target Ther.
6(73)2021.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Hu C, Zhao L, Liu W, Fan S, Liu J, Liu Y,
Liu X, Shu L, Liu X, Liu P, et al: Genomic profiles and their
associations with TMB, PD-L1 expression, and immune cell
infiltration landscapes in synchronous multiple primary lung
cancers. J Immunother Cancer. 9(e003773)2021.PubMed/NCBI View Article : Google Scholar
|
